Cancer, Ovarian Terminated Phase 2 Trials for DB00398 (Sorafenib)

Also known as: Cancer of the Ovary / Ovarian Cancer / Ovary Cancer / Cancer of Ovary / Ca ovary / Malignant tumor of ovary / Malignant neoplasm of ovary / Ovarian cancer NOS

IndicationStatusPhase
DBCOND0063542 (Cancer, Ovarian)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00522301Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second RemissionTreatment